Luminescent biomimetic citrate-coated europium-doped carbonated apatite nanoparticles for use in bioimaging: physico-chemistry and cytocompatibility by Gómez-Morales, Jaime et al.
  
 
 
OATAO is an open access repository that collects the work of Toulouse 
researchers and makes it freely available over the web where possible 
Any correspondence concerning this service should be sent  
to the repository administrator: tech-oatao@listes-diff.inp-toulouse.fr 
This is a Publisher’s version published in: http://oatao.univ-toulouse.fr/24526 
 
 
To cite this version:  
Gómez-Morales, Jaime and Verdugo-Escamilla, Cristóbal and Fernández-Penas, 
Raquel and Parra-Milla, Carmen María and Drouet, Christophe  and Bosc, 
Françoise  and Oltolina, Francesca and Prat, Maria and Fernández-Sánchez, 
Jorge Fernando Luminescent biomimetic citrate-coated europium-doped 
carbonated apatite nanoparticles for use in bioimaging: physico-chemistry and 
cytocompatibility. (2018) RSC Advances, 8 (5). 2385-2397. ISSN 2046-2069  
Official URL: https://doi.org/10.1039/C7RA12536D 
 
RSC Advances 
PAPE R View Article Online Vlew Journal I Vlew Issue l 11> Check for updates j Luminescent bio
Cite this: RSC Adv., 2018, 8, 2385
Reœived 17th November 20V 
Accepted 24th December 2017 
DOi: 10.1039/c7ra12536d 
rsc.11/rsc advanœs 
•Laboratoric de Estudics Crista!cgrqficos, !A
4. E 18100Annilla, Granada, Spain. E mail
•cIRIMAT, Université de rouleuse, UMR CNR
Monso, 31030 rouleuse Cedex 4, France 
'Dipartimento di Scienze della Salure, Uniwl
Via Sclaroli, 17, 28100 Novara, Italy 
"Department of Analytical. Chemist,y, Faculty
Fuentenuei,a sin, 18071 Granada, Spain 
t Electronic supplementary informa
10.1039/c7ra12536d 
This journal is © The Royal Society et Cmimetic citrate-coated europium­
doped carbonated apatite nanoparticles for use in 
bioimaging: physico-chemistry and 
cytocom pati bilityt 
Jaime G6mez Morales, CD*a Crist6bal Verdugo Escamilla, œa Raquel Fernândez 
Penas/ Carmen Marra Parra Milla,a Christophe Drouet, G)b Françoise Maube Bosc,b 
Francesca Oltolina,c Maria PratCDc and Jorge Fernando Fernândez SânchezG>d 
Nanomedicine covers the application of nanotechnologies in medicine. Of particular interest is the setup of 
highly-cytocompatible nanoparticles for use as drug carriers and/or for medical imaging. ln this context, 
luminescent nanoparticles are appealing nanodevices with great potential for imaging of tumor or other 
targetable cells, and several strategies are under investigation. Biomimetic apatite nanoparticles 
represent candidates of choice in nanomedicine due to their high intrinsic biocompatibility and to the 
highly accommodative properties of the apatite structure, allowing many ionic substitutions. ln this work, 
the preparation of biomimetic (bone-like) citrate-coated carbonated apatite nanoparticles doped with 
europium ions is explored using the citrate-based thermal decomplexing approach. The technique 
allows the preparation of the single apatitic phase with nanosized dimensions only at Eu3+ doping 
concentrations :s;Q.01 M at some timepoints. The presence of the citrate coating on the particle surface 
(as found in bone nanoapatites) and Eu3+ substituting ea2+ is beneficial for the preparation of stable 
suspensions at physiological pH. as witnessed by the Ç-potential versus pH characterizations. The 
sensitized luminescence features of the solid particles, as a function of the Eu3+ doping concentrations 
and the maturation times, have been thoroughly investigated, white those of particles in suspensions 
have been investigated at different pHs, ionic strengths and temperatures. Their cytocompatibility is 
illustrated in vitro on two selected cell types, the GTL-16 human carcinoma cells and the m17.ASC 
murine mesenchymal stem cells. This contribution shows the potentiality of the thermal decomplexing 
method for the setup of luminescent biomimetic apatite nanoprobes with controlled features for use in 
bioimaging. 1 Introduction 
Luminescent nanoparticles are excellent candidates for the 
setup of optical probes for use in medical and biological 
imaging. Their function is to provide the necessary fluorescence 
contrast required to visualize specific cellular components and 
tissues.' Severa! luminescent materials including quantum 
dots," nanodiamonds,• gold nanoparticles,• nanostructures CT {CSIC UGR}. Avda. Las Palmeras, No. 
:jaime@leccsic.es 
S/INPI'IUPS 5085, Ensiacet, 4Allée Emile 
rsità del Piemonte Orientale A Avogadro, 
 ofScienœs, Uniwlrsity of Granada, Avda. 
tion (ESI) available. See DOI: 
hemistry 2018 labeled with organic dyes,• nanoapatites labeled with organic 
dyes and monoclonal antibodies6 and rare earth-doped apatite 
nanomaterials'.a have been proposed as fluorophores for bio­
imaging and biosensing applications. Among them, lanthanide­
doped apatite nanoparticles have recently emerged as a new 
class of bioprobes exhibiting long fluorescence lifetime (sensi­
tized fluorescence), high quantum yield, sharp emission peaks, 
color tuning depending on the lanthanide ion doped and good 
resistance to photo-bleaching from environmental condi­
tions.7.9 As a host material, apatite provides a flexible crystal 
lattice to fix the dopant ion, whereas lanthanides offer the 
detectable and stable fluorescence signal. Compared to tradi­
tional fluorescence labeling procedures based on organic dyes 
or fluorescent proteins, which are prone to problems such as 
short luminescence lifetime, broad spectrum profiles, poor 
photochemical stability, and potential toxicity to cells,5 or to 
quantum dots, which are cytotoxic and show photoblinking,.,10 
the special features of lanthanide-doped apatite nanoparticles RSC Adv. 2018, 8, 2385 2397 1 2385
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View Article Onlinemakes them excellent candidates as bioprobes in medical
diagnostics and targeted therapeutics applications.11,12
In addition to be a very accommodative matrix for lantha-
nide ions, apatites also exhibit excellent properties such as
biocompatibility, bioactivity, biodegradability, and lack of
toxicity or inammatory and immune responses.13,15 Moreover,
they show good stability at physiological conditions of pH and
temperature; high loading capacity of biomolecules and drugs,
and ability to release the drugs in response to local stimuli such
as acidic pHs, as those found at tumor sites or within lyso-
somes, due to apatite progressive solubility in acidic conditions.
All these properties have been extensively exploited for hard
tissue repair and replacement, DNA loading, drug delivery,
passive and active targeting treatments of tumor cells, etc.13 18
The above properties can be enhanced by improving the
biomimetism of nanocrystalline apatites,19 that is, by preparing
them with similar dimensions, morphology, (nano)structural
and chemical characteristics of the natural biological ones.
Among diﬀerent synthetic routes to prepare biomimetic
apatites,13,20 we have proposed the thermal decomplexing of Ca/
citrate/phosphate/carbonate solutions21 25 which is a low cost,
eco-friendly and easily scalable method yielding highly mono-
disperse plate-shaped citrate-functionalized carbonate-apatite
nanoparticles with mean lengths ranging from 20 to 100 nm
and tailored carbonate content. The amount of citrate found
adsorbed on the nanoparticles is very similar to that measured
in bone carbonate apatite by Hu et al.26 Citrate ions can
modulate the physico-chemical characteristics of apatite
nanocrystals; they favor in particular their at morphology,
contribute to controlling the thickness of precipitated apatite
nanocrystals24 and aﬀect their interfacial properties by
decreasing the surface hydrophilicity.27 Although recent results
indicated that no organic template was strictly necessary to
obtain bone-like carbonated apatite crystals,28 the precipitation
of carbonated apatite in the presence of citrate has attracted
attention in modelling of bone mineralization since these small
organic molecules are present in vivo forming a coating on the
bone nanoapatites surface.26 In this context, the thermal
decomplexing method based on Ca/citrate/phosphate/
carbonate solutions has been proposed as an alternative route
to obtain biomimetic apatites both undoped and doped with
metallic ions.29
The aim of the present contribution was to investigate, in
detail and for the rst time, the possibility to obtain, in
a controlled way, luminescent biomimetic and highly-
biocompatible Eu-doped apatite nanoparticles via the thermal
decomplexing method, and to explore their physico-chemical
and cytocompatibility properties. It was reported that apatites
prepared in the presence of citrate by a hydrothermal method
exhibited a strong blue luminescence under UV lamp, mainly
due to the presence of adsorbed citrate.30 To explore the lumi-
nescence properties due to europium in this work we have
measured the sensitized uorescence of Eu(III). This condition
reduced/eliminated the uorescence background due to citrate.
In a rst stage, Eu-doped citrate-coated carbonated apatite
(Eu-doped cit-cAp) precipitates was generated by thermal
decomplexing of Eu3+/Ca2+/citrate/phosphate/carbonate2386 | RSC Adv , 2018, 8, 2385 2397solutions, and thoroughly characterized using a large set of
complementary techniques. Special attention was paid to
conditions allowing the obtainment of biomimetic features.
The luminescence properties of produced particles were then
explored by measuring the sensitized uorescence. Finally, the
cytocompatibility of such particles was investigated via in vitro
cell tests.2 Materials and methods
2.1 Reagents
Europium chloride hexahydrate (EuCl3$6H2O, ACS reagent,
99.9% pure), calcium chloride dihydrate (CaCl2$2H2O, Bioxtra,
99.0% pure), sodium citrate tribasic dihydrate (Na3(cit)$2H2O,
with cit ¼ citrate ¼ C6H5O7, ACS reagent, $99.0% pure), diso-
dium hydrogenphosphate (Na2HPO4, ACS reagent, $99.0%
pure), sodium carbonate monohydrate (Na2CO3$H2O, ACS
reagent, 99.5% pure) and hydrochloric acid (HCl, ACS reagent,
37 wt% in H2O) were provided by Sigma-Aldrich. All solutions
were prepared with ultrapure water (0.22 mS, 25 C, Milli-Q,
Millipore).2.2 Precipitation method
The experiments were carried out by thermal treatment of
metastable solutions containing Eu3+/Ca2+–citrate complexes in
the presence of phosphate and carbonate ions, at pH ¼ 8.5.
Powders were synthesized as follows: 50 mL of a solution (a) of
composition 0.06 M Na2HPO4 + 0.1 M Na2CO3 was poured into
50 mL of a solution (b) of composition 2xEuCl3 + 2yCaCl2 +
0.2 M Na3(cit), with x¼ 0.001, 0.005, 0.01, 0.02 and 0.03 M and y
¼ 0.1 x M, at 4 C. Then, the pH was adjusted to 8.5 with
diluted HCl. The undoped sample (cit-cAp) was obtained using
a 0.10 M CaCl2 europium-free solution in the aforementioned
procedure. The mixed solution was introduced into a 200 mL
bottle made of glass Pyrex®, sealed with a screw cap, immedi-
ately submerged in a water bath at 80 C and then put in an oven
with circulated forced air at the same temperature. The exper-
iments lasted between 1 and 96 hours, except at some Eu3+
concentrations for which longer maturation times were used
(mentioned in the text). Upon completion, the precipitates were
subjected to 6 consecutive cycles of washing by centrifugation
with ultrapure water to remove unreacted species or salts such
as NaCl. Aerwards they were freeze-dried overnight at 50 C
under vacuum (3 mbar). The theoretical reaction yielding Eu-
doped carbonated apatites can be represented by eqn (1):
(5 x)[Ca(cit)] + x[Eu(cit)]0 + 3HPO4
2 + 5/3CO3
2
+ OH/ Ca5xEux(PO4)3z(CO3)z(OH)1z(CO3)z
+ 5cit3 + 3H+ + nCO3
2 with z ¼ 5/3 n (1)
2.3 Particle characterization
Diﬀerent techniques were used for the characterization of the
precipitates including X-ray diﬀraction (XRD), FTIR spectros-
copy, atomic absorption spectroscopy (AAS), visible spectro-
photometry, scanning and transmission electron microscopyThis journal is © The Royal Society of Chemistry 2018
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
Ja
nu
ar
y 
20
18
. D
ow
nl
oa
de
d 
on
 1
0/
24
/2
01
9 
7:
37
:3
4 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online(SEM and TEM) and energy dispersive X-ray spectroscopy (EDS)
analysis. Selected samples were additionally analyzed by
dynamic light scattering (DLS) and x-potential against pH.
XRD data were collected by using a Bruker D8 Advance Vario
diﬀractometer with a Bragg–Brentano parafocusing geometry and
Cu Ka1 radiation (1.5406 A˚). Data processing was conducted by
using the soware Diﬀract EVA from Bruker and Profex based on
the Rietveld renement kernel BGMN.31 The approach used by this
soware to determine the anisotropic size broadening contribu-
tion was used to determine the crystallite size. The instrumental
contribution to the peak width was taken into account and
calculated from the LaB6 standard supplied by NIST (SRM 660c).
SEM observations and EDS were performed with both a eld
emission high resolution microscope FEG-ESEM QUEMSCAN
650F equipped with Dual EDS XFlash from Bruker with a XFlash
6/30 X-ray detector, and a variable pressure Zeiss SUPRA40VP
scanning electron microscope (VPSEM). This instrument is
provided of a large X-Max 50 mm area detector for energy
dispersive X-ray spectroscopy (EDS) microanalysis. The powder
samples were ultrasonically dispersed in deionized water and
then a few droplets of the slurry were deposited on conventional
supports, then dried and carbon-sputtered, prior observation.
Eu, P and Ca were determined averaging 7–10 measurements in
diﬀerent Eu-apatite particles of each sample.
Transmission electron microscopy (TEM) observations were
performed with a Carl Zeiss Libra 120 microscope operating at
80 kV. The powder samples were ultrasonically dispersed in
ethanol (absolute, $99.8%), and then a few droplets of the
slurry were deposited on formvar coated copper microgrids
prior to observation.
Fourier transform infrared spectra were initially recorded with
a JASCO 6200 FTIR spectrometer equipped with an attenuated
total reectance (ATR) accessory of diamond crystal. For more
advanced IR investigations, transmission FTIR spectra were
recorded on selected samples using a Perkin-Elmer SpectrumOne
FTIR spectrometer. The pellets were prepared by mixing1mg of
sample with 100 mg of anhydrous KBr and then pressed with
a hydraulic pump at 10t into 13 mm diameter discs. Pure KBr
pellets were used to record the background. FTIR spectra in
transmittance mode were recorded within the wavenumber range
from 4000 cm1 to 400 cm1 at a resolution of 4 cm1.
Calcium and europium contents were measured by AAS
using atomic absorption bands located at 422.7 and 459.4 nm
respectively for calcium and europium. AAS spectra were ob-
tained on a ContrAA 300 High-Resolution Continuum Source
Atomic Absorption Spectrometer from Analytik Jena AG, oper-
ated in a nitrous oxide-acetylene ame, in acidic conditions via
addition of perchloric acid HCLO4 6 M down to pH close to 2
and in the presence of cesium chloride (starting reagent: CsCl
1%). Phosphate titrations were carried out by visible spectro-
photometry using the vanado–molybdeno–phosphate yellow
complex whose absorbance at 460 nm is directly related to the
phosphate concentration in solution.
The analysis of the particle size distribution and electro-
phoretic mobility (z-potential) of samples were performed using
a Zetasizer Nano ZS analyzer provided of a 633 nm laser (Mal-
vern, UK) using disposable polystyrene cuvettes containing theThis journal is © The Royal Society of Chemistry 2018particles suspended in deionized water (0.5 mg mL1) at 25 C.
For the measurements of the z-potential versus pH, the MPT-2
autotitrator (Malvern, UK) connected to the analyzer was
employed. Diluted HCl and NaOH solutions (0.25 and 0.1 M,
respectively) were used as titration agents. No additional elec-
trolytes were added.
2.4 Luminescence spectroscopy
The luminesce properties (excitation and emission spectra and
lifetime) of solid europium-doped particles and their aqueous
suspensions (0.5 mgmL1) were recorded using a Cary Eclipse
Varian Fluorescence Spectrophotometer (Varian Australia,
Mulgrave, Australia). A front surface accessory was used to
obtain the luminescence spectra, the luminescence lifetime and
the relative luminescence intensities of the powders and
a commercial Peltier cell holder connected to a temperature
control module (Agilent Technologies, Madrid, Spain) was used
to obtain the luminescence spectra and the relative lumines-
cence intensities (R.L.I.) of the liquid suspensions. The instru-
mental parameters for characterizing the solid particles in
powder were: lexc ¼ 394 nm, lem ¼ 614 nm, slit-widthsexc/em ¼
5/5 nm, delay time (td) ¼ 0.120 ms, gate time (tg) ¼ 5 ms and
detector voltage ¼ 500 V. The instrumental parameter for the
characterization of the particles in aqueous suspensions were:
lexc¼ 232 nm, lem¼ 616 nm, slit-widthsexc/em¼ 10/10 nm, delay
time (td)¼ 0.120 ms, gate time (tg)¼ 5 ms and detector voltage¼
600 V. Luminescence lifetimes (s) were measured in solid
samples prepared at the higher maturation times using the
following conditions: lexc/em ¼ 229/614 or 240/614 nm,
slit-widthsexc/em ¼ 5/5 nm, td ¼ 0.1 ms, tg ¼ 0.1 ms and detector
voltage ¼ 550 V. The eﬀect of several chemical conditions over
the luminescence properties of the aqueous suspensions
prepared from powders of the higher maturation times were
also evaluated: concentration of nanoparticles in suspension
(0–100 mM), temperature (25 C, 37 C), pH (5.0–7.5) and ionic
strength (0–100 mM NaCl).
2.5 Cytotoxicity tests
GTL-16 (a human gastric carcinoma cell line, obtained aer
cloning the MNK45 cell line, and at its passage 7032,33, at Dept of
Health Sciences, Universita` del Piemonte Orientale, 28100
Novara) and m17.ASC (a spontaneously immortalized mouse
mesenchymal stem cell clone from subcutaneous adipose
tissue, obtained in the same labs, at its passage 7834) cells
(12 000 and 5000 cells per well in 96-well plates, respectively)
were incubated for 24 hours and then diﬀerent concentrations
of the diﬀerentially doped (x ¼ 0.001, 0.005, 0.010, 0.020 and
0.030 M Eu3+) particles, ranging from 0.1 to 100 mg mL1, were
added in 100 mL of fresh medium. Aer 72 hours incubation,
cell viability was evaluated by the (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) (MTT, Sigma) colorimetric
assay. Briey, 20 mL of MTT solution (5 mg mL1 in a PBS
solution) were added to each well. The plate was then incubated
at 37 C for 3 hours. Aer the removal of the solution, 125 mL of
0.2 M HCl in isopropanol were added to dissolve formazan
crystals. 100 mL were then removed carefully and the opticalRSC Adv , 2018, 8, 2385 2397 | 2387
Table 1 Europium, calcium and phosphate titrations of the solid
phases precipitated by citrate-based thermal decomplexation, versus x
(for t 96 h)
Value of x (in M) Eu/(Ca + Eu) (Ca + Eu)/P
0 0 1.60
0.02 0.22 1.44
0.03 0.33 1.24
0.04 0.40 1.17
0.05 0.53 1.09
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View Article Onlinedensity was measured in a multiwell reader (2030 Multilabel
Reader Victor TM X4, PerkinElmer) at 570 nm. Viability of
parallel cultures of untreated cells was taken as 100% viability,
and values obtained from cells undergoing the diﬀerent treat-
ments were referred to this value. Experiments were performed
4 times using 3 replicates for each sample.2.6 Statistical analysis
Data are expressed as mean  standard deviation of at least
three replicates. Statistical analyses were performed using
a one-way ANOVA with Bonferroni's post test for grouped
analyses using GraphPad Prism version 4.03 for Windows,
GraphPad Soware (GraphPad Prism, San Diego, CA). Diﬀer-
ences at p < 0.05 were considered to be statistically signicant.Fig. 1 XRD diagrams of samples precipitated at diﬀerent times in the pr
0.001 M; (c) 0.005 M; (d) x 0.010 M. #(OCP, 100, PDF 44-0778), *(apa
2388 | RSC Adv , 2018, 8, 2385 23973 Results and discussion
3.1 Preliminary thermal decomplexing experiments and
chemical titrations on precipitates
A series of synthesis experiments was rst carried out by citrate-
based thermal decomplexing for 96 h and using increasing
europium concentrations in a wide range of values (x between
0 and 0.05 M) for a preliminary screening of precipitation
conditions.
Table 1 reports the Eu/(Ca + Eu) and the (Ca + Eu)/P molar
ratios as drawn from atomic absorption (Ca and Eu) and spec-
trophotometry (P) analyses. These results point out the signi-
cant eﬀect of europium on the precipitation events occurring
during thermal decomplexation. While the nature of the
precipitated phases will be investigated in the following
sections, these data already show that europium has indeed
been incorporated in all the precipitates, and in increasing
amounts.3.2 X-ray diﬀraction patterns of precipitated solids
The XRD diagrams of the samples precipitated in the absence
(x ¼ 0) and presence of Eu3+ doping concentrations (x from
0.001 to 0.01 M) are reported on Fig. 1. They show rather similar
evolutions with time, although increasing concentrations in
europium leads to slowing of the precipitation process as wit-
nessed by the broad peaks observed at the lowest timepoints foresence of the following Eu3+ doping concentrations: (a) x 0; (b) x
tite phase, PDF 01-1008).
This journal is © The Royal Society of Chemistry 2018
Fig. 2 XRD patterns of samples precipitated at 96 hours in the
absence (x 0) and the presence of Eu3+ (x 0.001, 0.005, 0.020 and
0.030 M) and at 7 days (x 0.01 M). #(OCP, 100, PDF 44-0778),
*(apatite phase, PDF 01-1008), +(EuPO4$H2O phase, PDF 20 1044).
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View Article Onlinex ¼ 0.005 and 0.01 M Eu3+. Early in time, however, all samples
started to display the main distinguishing XRD reections of an
apatite phase (PDF 01-1008), for example with peaks at 2q ¼
25.87 corresponding to the (002) plane, the triplet at 31.77,
32.19 and 32.90 (planes (211), (112) and (300)) respectively,
the reections at 33.9 and 39.81 (planes (202) and (310)) and
other minor peaks in the 2q range from 40–55.29
The nanocrystalline character of the particles was assessed
by applying the Rietveld method as implemented in Profex
soware (Table 2), giving an estimate of the mean length and
width/depth of the apatite nanocrystals formed. Dimensional
considerations will be discussed later, in the section dedicated
to microscopy analyses. Due to the nanocrystalline character of
the particles the reections in the 2q range 31–34 are seen as
a broad peak. Only for maturation times longer than 4 hours the
three peaks can be detected isolately. For x ¼ 0.005 and 0.010 M
Eu3+, the presence of octacalcium phosphate (OCP), small and
wide reection at 4.74, plane (100), (OCP, PDF 44-0778) is also
noted for maturation times from 5 min to 4 hours. This
reection is not observed in precipitates matured for more than
4 hours, which in turn show the main reections of the apatite.
The width of the reection at 4.74 along with the bulging of the
baseline in the interval 23–38 may be attributed to the nano-
crystalline character of the precipitated calcium phosphate
phase.
For x ¼ 0.02 M Eu3+ both the reection at 4.74 of OCP and/
or the bulging of the baseline in the interval 23–38 are present
at all maturation times tested. At 96 hours, in addition, strong
and narrow apatite peaks emerging from the bulged baseline
are observed, which indicates that bigger apatite crystals coexist
with the OCP phase (Fig. 2 and SI1, see ESI†). Finally, for x ¼
0.03 M Eu3+ the OCP phase forms for all maturation times from
5 min to 96 hours and coexists with apatite at this last time-
point. Besides this reection, the crystallographic features ofTable 2 Crystalline phase composition, Ca/P ratio, percent weight of Eu3
by SEM and/or TEM and average dimensions (length, width) of the cryst
[Eu3+]0, M (x) Crystalline phases
a Ca/P ratiob wt% Eub
0.001 4 h Ap 1.59  0.14 1.72  0.31
0.001 24 h Ap 1.65  0.24 1.56  0.37
0.001 96 h Ap 1.63  0.09 2.04  0.27
0.005 4 h Ap + OCP 1.34  0.42 14.6  2.1
0.005 24 h Ap 1.53  0.12 6.40  0.48
0.005 96 h Ap 1.48  0.18 5.25  0.68
0.010 4 h Ap + OCP 1.08  0.54 23.8  5.7
0.010 24 h Ap 1.08  0.15 24.0  7.7
0.010 96 h Ap 1.54  0.14 11.5  0.3
0.010 7 d Ap 1.53  0.04 5.4  1.2
0.020 4 h Ap + OCP 0.98  0.02 13.0  0.3
0.020 24 h Ap + OCP 1.05  0.03 20.6  0.4
0.020 96 h Ap + OCP 1.45  0.01 13.3  2.6
0.030 96 hc Ap + OCP 1.56  0.01 10.03  0.3
a Ap apatitic phase; OCP octacalcium phosphate. b Measured by EDS
phase. c At this timepoint the europium phosphate phase started to appear
considered only as an estimated trend. They are accurate only for dimensio
instrumental FWHM contribution and the FWHM contribution due to th
This journal is © The Royal Society of Chemistry 2018a hexagonal phase identied as EuPO4$H2O (PDF 20 1044) are
also observed at 96 hours (Fig. 2 and SI1†). A last precipitate
obtained at 21 days is composed of the EuPO4$H2O phase and
apatite, showing that for high Eu3+ amounts in the solution,
europium phosphate precipitates beside apatite.
Taking into account that OCP is a known precursor for
apatite formation, all the above results strongly suggest that the
presence of europium ions in the precipitating medium
signicantly modies the progression of apatite precipitation.
This can most likely be related to an inhibitory eﬀect of Eu3+ on
apatite crystallization, as was already pointed out in the litera-
ture.9 These results however also indicate that adequate+ in the samples, average particle dimensions (length, width) measured
alline domains determined by Rietveld reﬁnement
L (nm) W (nm) L (nm) (Rietveld) W (nm) (Rietveld)
23.5  5.4 23.5  5.4 25.4  6.9 7.9  0.9
38.7  5.8 18.7  6.2 32.9  8.3 11.2  1.2
39.2  5.3 9.6  1.4 35.1  0.5 11.7  0.1
65.3  9.3 65.3  9.3 26  0.9 5.1  0.1
170.4  6.5 52.5  6.4 41.2  0.7 9.1  0.1
127  27 17.9  7.2 39.7  0.7 9.3  0.1
526  235 134.5  40.7 54.7  6.4 31.2  1.4
325  50 73  7 79.7  3.6 60.4  1.4
380  65 92  12 80.5  2.2 53.5  0.7
90  21 90  21 30.6  0.8 13.6  0.1
340  50 75  10 92.3  2.3 62.3  1.3
1250  15 225  40 328  5.6 d 247  4.1d
1870  100 260  45 567  4.5d 166  3.2d
1230  50 210  55 643  10.2d 128  9.8d
technique averaging the composition of 6 10 diﬀerent zones of the Ap
. d Calculated crystallite dimensions greater than 100 150 nm have to be
ns below these sizes, because for bigger sizes the diﬀerence between the
e size is negligible.
RSC Adv , 2018, 8, 2385 2397 | 2389
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View Article Onlineconditions for the thermal decomplexing approach can be
determined for leading to the precipitation of an apatitic phase
alone, as for example using x ¼ 0 to 0.02 for 96 h, (Fig. 2). Such
apatites precipitated as single phases by the thermal decom-
plexing method exhibited a Eu/(Ca + Eu) molar ratio varying
between 0 and 0.22, as reported in Table 1, evidencing a large
incorporated europium content, as well as a (Ca + Eu)/P molar
ratio signicantly lower than 1.67 pointing out their non-
stoichiometry as for bone apatite.133.3 FTIR spectroscopy
For complementary characterization, the samples were also
analyzed by FTIR. The example of the compound corresponding
to x¼ 0.01 at 96 h maturation is shown on Fig. 3, in comparison
to a stoichiometric hydroxyapatite reference sample. Typical
bands characteristic of poorly-crystallized carbonated apatite
can be observed.
Generally speaking, all spectra of Eu-free and Eu-doped
specimens (x ¼ 0.001 M to 0.010 M Eu3+) at maturation times
of 96 hours were found to exhibit a broad band between
3600 cm1 and 2600 cm1 corresponding to O–H stretching
from adsorbed water while no clear detection of apatitic OH
bands around 3570 cm1 was made, as is customary for bio-
inspired apatites. The 400–1800 cm1 region was more speci-
cally analyzed, allowing to visualize typical spectral features of
apatitic compounds. The main band at 1000–1100 cm1
(Fig. 4a) corresponds to the asymmetric stretching mode of
PO4
3 groups (y3PO4). The shoulder at965 cm1 is ascribed to
the symmetric stretching (y1PO4) while less intense bands at
608 and 565 cm1 are due to the bending mode of PO43
groups (y4PO4). The band at 535 cm1 in the y4PO4 domain
can be assigned to non-apatitic (surface) HPO4
2 ions, also
clearly visible on Fig. 3, which points to the biomimetic nature
of the precipitated nanocrystalline apatite in these
compounds.35 Note however that this band is not clearly
detected in the spectra of the Eu-free sample nor in the spectraFig. 3 FTIR spectrum for the sample precipitated in the presence of
Eu3+ doping concentration x 0.01 M, at 96 hours, and for a stoi-
chiometric hydroxyapatite reference compound. Main bands attribu-
tions are indicated.
Fig. 4 FTIR spectra of samples prepared: (a) in the presence of Eu3+
doping concentrations from x 0.00 to 0.030 M, at 96 hours and (b)
for x 0.010 M Eu3+at maturation times between 5 min to 7 days. (c)
Detailed FTIR analysis of the y2CO3 region for sample prepared in
presence of 0.01 M Eu3+ at 96 h maturation.
2390 | RSC Adv , 2018, 8, 2385 2397of specimens prepared with doping concentrations 0.001 M and
0.005 M Eu3+ at the same times. However, it is important for
0.010 M Eu3+ at the lower maturation times, between 5 min and
4 hours (Fig. 3 and 4b). These ndings reveal that, using this
methodology of thermal decomplexing, a certain amount of
europium is needed in the medium to play an eﬀective inhib-
iting role on apatite crystallization, thus generating moreThis journal is © The Royal Society of Chemistry 2018
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View Article Onlineimmature apatite nanocrystals exhibiting larger non-apatitic
surface layers.35 This, again, indicates the biomimetic nature
of apatite crystals precipitated by the thermal decomplexing
method, e.g. for x ¼ 0.01 M Eu3+.
The presence of carbonate (CO3
2) bands is attested by
vibrational signatures due to the y3CO3 mode, with maxima
around 1414 cm1 and 1473 cm1, and the y2CO3 mode with
a bulging peak around 873 cm1 (Fig. 4). From the intensity of
FTIR carbonate bands relative to phosphate ones, it is possible to
evaluate the overall degree of carbonation of the apatite phase.
This quantication methodology has recently been revisited by
Grunenwald et al.36 using the area ratio rc/p between the y3CO3
and the y1y3PO4 contributions, between selected integration
limits. Following this method, a rc/p ratio of 0.3185 is calculated,
leading to an overall carbonation of sample x ¼ 0.01 (96 h) esti-
mated to 9.2  0.5 wt%. This degree of carbonation may be
somewhat overestimated due to partial overlapping with carbox-
ylate COO citrate bands (especially the one located at 1466 cm1
(ref. 37)). The present precipitating conditions however lead to
signicantly larger carbonation than previously reached (up to
5.9 wt%) via the citrate-based thermal decomplexing approach.23
Detailed analysis of the y2CO3 region was carried out to
inspect the chemical environments of the carbonate species
within the apatite phase (Fig. 4c). Spectral decomposition
indicates that three contributions co-exist, at 879 (smaller
shoulder), 873 (main contribution), and 868 (shoulder) cm1.
These bands are respectively attributable to A-type (minor),
B-type (major), and labile (intermediate intensity) carbonate
species.38 While A- and B-type correspond to carbonate ions
replacing lattice ions (respectively OH and PO4
3) in apatite
nanocrystals bulk, labile carbonates correspond to surface
carbonate species belonging to the hydrated non-apatitic layer
on the nanocrystals. CO3
2 ions replacing tetrahedral PO4
3
groups (B-type carbonation)23 are found here to be predomi-
nant. This is in agreement also with the positions of the 1414/
1473 cm1 bands from the y3CO3 mode; however the co-
presence of labile carbonate species is another feature point-
ing to the biomimetic character of the samples precipitated by
this thermal decomplexing route, including in the presence of
europium ions.
Beside apatitic vibrational contributions, a band at
1590 cm1 is also noticed on all samples, which can be
ascribed to the antisymmetric stretching frequencies of the
carboxylate groups of the citrate. This band is sharper than that
corresponding to the Eu-free sample, indicating a higher
adsorption of citrate to the crystal surface due to the incorpo-
ration of Eu3+. Bands at 2930 cm1 and 840 cm1 are
assignable to yCH2 and dCOO modes39 of the citrate ions,
respectively. Note that the citrate layer (composed of citrate and
Na+) adsorbed to Eu-Ap nanocrystals can be removed aerward
by washing the crystals in a basic solution (NaOH 0.1 M), as we
demonstrated in a previous work.293.4 Scanning and transmission electron microscopy
The morphological aspects of the particles composing the
precipitates obtained for x ¼ 0.001 M to x ¼ 0.030 M Eu3+ areThis journal is © The Royal Society of Chemistry 2018shown in Fig. 5. TEM micrographs (Fig. 5a and b) conrm the
nanocrystalline character of the precipitates obtained for x <
0.010 M Eu3+ (t ¼ 96 hours). For x ¼ 0.010 M, SEM micrographs
(Fig. 5d–f) show the formation of elongated hexagonal prisms of
submicron or micron sizes at precipitation times below or equal
to 96 h. Longer precipitation times (at least 7 days) are needed
to obtain the characteristic features of Eu-doped nanocrystal-
line apatites (Fig. 5c). For x ¼ 0.020 M Eu3+ (Fig. 5g and h)
a mixture of small quasi spherical OCP nanocrystals (Fig. 5g)
and elongated apatite microcrystals (Fig. 5h) is observed. The
same occurred for x ¼ 0.030 M (Fig. 5i). The conditions x ¼
0.010M Eu3+ andmaturation time 96 hours are, thus, the pair of
conditions representing a boundary for the precipitation of the
Eu-doped apatites with ‘nanosized’ dimensions, which is
among the objectives of our study.
Table 2 summarizes the main characterization results ob-
tained in this work, including the crystalline phase composition
of the precipitates, the evolution with the maturation time of
dimensions of the crystalline domains of the Eu-doped cit-cAp,
the average dimensions of the particles (length and width), the
Ca/P ratio and the percentage of europium incorporated in the
doped nanoparticles, as evaluated by EDS analyses. For the sake
of simplicity, only the results obtained at some of the matura-
tion times are shown.
The presence of nanoparticles (L < 100 nm) is observed only
for x¼ 0.001, 0.005 and 0.010 M Eu3+ at 7 days. The evolution of
the particle dimensions (L, W) with the maturation time
depends on the doping concentration. For x ¼ 0.001 and
0.005 M Eu3+ L increases while W decreases. For x ¼ 0.010 M
Eu3+ both L and W decrease until reaching nanosized dimen-
sions at 7 days. For x¼ 0.020 M Eu3+ both L andW increase. The
same trend is observed when we analyze the dimensions of the
crystalline domains via the Profex soware. Both particle size
and dimensions of the crystalline domains are similar only
when the particle size is less than 40 nm, i.e. for x ¼ 0.001 M
Eu3+. Concerning the incorporation of europium during the
formation of Eu-doped cit-cAp we observed similar trends irre-
spective of x. At x¼ 0.001 M Eu3+, the nanoparticles incorporate
only z2 wt% Eu3+ at any maturation time. For x ¼ 0.005,
0.010 M the europium contents are lower at the higher matu-
ration times (i.e. 5.25 wt% against 14.6 wt% for x ¼ 0.005 M
Eu3+, 5.4 wt% against 23.8 wt%), indicating that increasing the
time favors the Ca2+ to be accommodated in the apatitic struc-
ture against Eu3+. This is reected in a Ca/P ratio closer to the
theoretical one of a stoichiometric hydroxyapatite (1.67). For x¼
0.020 M Eu3+ the Eu content of around 13 wt% is kept constant
with the maturation time.
Considering that EuCl3 and Na2CO3 are reagents used in the
precipitation experiments and Eu3+, Na+ and CO3
2 are prone to
entering the apatite structure, an anionic–cationic multiple
substitutionmechanismmight be active during the formation of
the doped apatite.40,41 One likely mechanism implies that 2 Eu3+
ions substitute 3 Ca2+ generating a Ca2+ vacancy,41 while Na+ and
CO3
2 can substitute Ca2+ and PO4
3 in B-position, respectively,
by any of six fundamental mechanisms reported by Maeyer and
Verbeeck or by a linear combination of some of them.42RSC Adv , 2018, 8, 2385 2397 | 2391
Fig. 5 (a c) TEMmicrographs of precipitates obtained for Eu3+ doping concentrations x 0.001 M (96 h), x 0.005 M (96 h) and x 0.010 M (7
days) respectively; (d f) SEMmicrographs of precipitates obtained for x 0.010M Eu3+ at 4 h, 24 h and 96 h, respectively; (g, h) SEMmicrographs
of the sample precipitated in presence of x 0.020 M Eu3+ at 96 h showing, respectively, a population of small quasi spherical OCP nanocrystals
and apatitemicrocrystals. (i) SEMmicrograph of a sample precipitated in presence of x 0.030M Eu3+ showing amixture of apatitemicrocrystals
and OCP nanoparticles.
Fig. 6 (a, b) z-potential vs. pH of suspensions containing Eu-doped cit-cAp, Eu-doped carbonated apatites without citrate (Eu-doped cAp),
citrate coated Eu-free samples (cit-cAp) and carbonated apatite without the citrate layer (cAp) (a) x 0.010 M Eu3+ and (b) x 0.020M Eu3+. The
citrate layer was removed by washing the particles with 0.1 M NaOH solution.
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View Article OnlineDuring the doping process Eu3+ substitutes Ca positions in
the cit-cAp structure. In the apatitic unit cell there is a total of 10
calcium ions per unit cell, with four of them in Ca(I) positions,
which are in columns parallel to the c-axis. Each Ca(I) is sur-
rounded by nine oxygen atoms. The other six calcium ions per
unit cell, called Ca(II), form two equilateral triangles localized
along the c-axis at z ¼ 1/4 and 3/4, a so-called anion channel,
which is typically occupied by monovalent anions.43 Site Ca(I) is
smaller in volume than site Ca(II). As the Eu3+ ionic radius (1.08
A˚) is slightly higher than the ionic radius of Ca2+ (0.99 A˚), we can2392 | RSC Adv , 2018, 8, 2385 2397speculate that Eu3+ is more prone to occupy Ca(II) positions.
However, we have no data to properly assign the substitution in
these two non-equivalent positions.3.5 Electrokinetic properties of Eu-doped cit-cAp
nanoparticles
An important property of colloidal Eu-doped cit-cAp suspensions
regarding its potential applications as drug delivery vehicles or as
luminescent probes is the z-potential of the suspensions vs. pHofThis journal is © The Royal Society of Chemistry 2018
Fig. 7 Excitation (dashed lines) and emission (solid lines) spectra of
Eu-doped cit-cAp prepared with 0.02 M Eu3+at maturation times of
5 min, 1 h, 2 h, 4 h, 24 h, 48 h and 96 h. Slit-widthsexc/em 5/5 nm, td
0.120 ms and tg 5 ms.
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View Article Onlinethe medium, which inuences the aggregation state of the
particles. Fig. 6a and b depict the evolution of z-potential for the
cases x ¼ 0.010 M and x ¼ 0.020 M Eu3+ respectively. In both
series, four samples were analyzed: Eu-doped cit-cAp, Eu-doped
cAp, cit-cAp and cAp (see caption of Fig. 6).
The general trend observed along the whole pH range (from
3 to 11) is the decrease of the z-potential in the order: cAp > cit-
cAp > Eu-doped cAp > Eu-doped cit-cAp. For each subsystem, the
presence of the citrate layer and Eu3+ substituting Ca2+ in the
apatite structure leads the z-potential to be more negative until
levels allowing the preparation of stable suspensions. For x ¼
0.010 M Eu3+ at pHs 7 and 5 these values are 18.7 and
12.2 mV, whereas for x¼ 0.020 M Eu3+ they are more negative,
around 35.3 and 29.0 mV. These pHs are close to the phys-
iological pH in the blood circulation and the more acidic pH in
the endosome–lysosome intracellular compartment, respec-
tively. In contrast, aqueous suspensions of cAp show z-potential
values closer to 0 except at high pHs, indicating that they are the
least stable suspensions. The negative values of the z-potential
found for the cit-cAp is explained on the basis of the interaction
of the negatively charged free carboxylate groups (–COO) of
the adsorbed citrate layer with the aqueous medium. This
interaction is stronger than that produced by the Cad+, >PO4
d,
>CO3
d,>OHd surface groups of cAp nanoparticles. The
incorporation of Eu3+ in the apatite structure (case of Eu-doped
cAp) originates Ca2+ vacancies in the bulk structure as well as in
the surface of the nanoparticles, thus making the surface more
negatively charged. In the Eu-doped cit-cAp samples, this
negative charge is increased by the presence of the citrate layer.This journal is © The Royal Society of Chemistry 20183.6 Luminescence properties of solid Eu-doped cit-cAp
samples
Some lanthanides, especially Eu3+ and Tb3+, form highly uo-
rescent chelates with many diﬀerent organic ligands. The
sensitized uorescence results from the ligand absorbing light,
the energy of which is then transferred to the chelated metal
ion. In fact, Eu3+ emits the energy as narrow-banded, line-type
uorescence with a long Stokes shi (over 250 nm) and an
exceptionally long uorescence decay time (up to 1 ms).44
Because of the long uorescence decay time (over 10 times
longer than the average background uorescence) of Eu3+,
a delay time (td) and a gate time (tg) can be used during the
measuring, remarkably reducing the background uorescence.
The luminescence properties of solid Eu-doped cit-cAp
samples are depicted in Fig. 7 and SI2 of ESI† which show the
uncorrected excitation and emission spectra.
The observed excitation wavelengths for the powder were
320, 362, 380, 394 and 465 nm which correspond to the Eu3+ ion
7F0/
5H6,
7F0/
5D4,
7F0/
5L7,
7F0/
5L6, and
7F0/
5D2
transitions, and the emission wavelengths were 576, 590, 614,
650 and 698 nm, which correspond to the Eu3+ ion 5D0/
7F0,
5D0/
7F1,
5D0/
7F2,
5D0/
7F3 and
5D0/
7F4 transitions,
respectively.45 The emission wavelength corresponding to the
hypersensitive transition without inversion center (5D0/
7F2,
614 nm) produces the highest relative luminescence intensity,
while the 5D0 /
7F0 produces the lowest one. Therefore, the
optimum excitation and emission wavelengths of solid Eu-
doped material were 394 nm and 614 nm, respectively. The
cit-cAp sample, free of Eu3+, does not show any luminescence
emission (see ESI, Fig. SI2a†), thus it is possible to deduce that
the luminescent properties of these materials are only due to
the incorporation of Eu3+ into their structure. Ternane et al.46
pointed out that three kinds of spectroscopic sites could be
distinguished for 5D0/
7F0 transitions of Eu
3+. The former two
sites were associated with 5D0/
7F0 emission of Eu
3+ ions in
Ca(II) sites and the latter one was associated with that in Ca(I)
sites. The intensity ratio of the emissions in Ca(I) respect to
Ca(II) was about 1/20. In our experiments the low intensity of the
5D0/
7F0 transition at 575 nm does not allow us to deconvolute
the small peak in Fig. 7. Therefore we deduce that it is mostly
associated with Eu3+ in Ca(II) positions.
Fig. SI3 and SI4 (see ESI†) also show the eﬀect of the matu-
ration time and concentration of Eu3+ on the luminescence
properties. It is possible to observe that neither the maturation
time nor the concentrations of doping agent aﬀect the excita-
tion and emission wavelengths. Nevertheless, the relative
luminescence intensity (R.L.I.) is aﬀected by both parameters.
The evolution of the R.L.I. versus maturation time for
0.001 M Eu3+ doping concentration does not report any relevant
information because the luminescence emission is too weak
and the measurement errors might be higher than the lumi-
nescent changes. 0.005 and 0.010M Eu3+ doping concentrations
show similar evolutions with the precipitation time; the highest
signal is obtained at t ¼ 5 min, then a decrease of the lumi-
nescence emission is observed up to 24 h, maintaining this
emission for larger times. These observations agree with theRSC Adv , 2018, 8, 2385 2397 | 2393
Fig. 8 Luminescence decay curve of Eu-doped cit-cAp prepared with diﬀerent Eu3+ doping concentrations at maturation times of 96 h. lexc/em
394/614 nm, slit-widthsexc/em 5/5 nm and detector voltage 550 V. Circles correspond to experimental data and lines to the ﬁtting equation.
Fig. 9 Excitation (dashed line) and emission (solid line) spectra of Eu-
doped cit-cAp samples prepared with diﬀerent Eu3+ doping concen-
trations at 96 h suspended in water at 25 C and pH 7.0. Slit-
widthsexc/em 5/5 nm, td 0.120 ms and tg 5 ms.
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View Article Onlineevolution of the Eu incorporated to the solids (Table 2) and
might be linked to the formation of transient metastable
intermediate phases incorporating europium ions and for
which luminescence yield could be high. XRD data (Fig. 1)
indeed pointed out poorly crystallized samples for low matu-
rations times. Samples prepared with 0.020 and 0.030 M Eu3+
doping concentrations show similar evolutions with time;
a high signal is obtained at t ¼ 5 min, then the R.L.I. decreases
up to 48 h and increases for 96 h.
Concerning the eﬀect of the Eu3+ doping concentration,
Fig. SI4 of ESI† shows the evolution of the R.L.I. for a xed
precipitation time versus the concentration of Eu3+. The
evolution for 5 min and 1 h is practically the same; the R.L.I.
increases with the concentration of Eu3+, reaching the
maximum R.L.I. at 0.030 and 0.020 M, respectively. Precipita-
tion times of 2, 4 and 24 h, show similar variations; the R.L.I.
increases from 0 to 0.010 M, then it is maintained from 0.01 to
0.02 M and for Eu3+ concentrations higher than 0.02 M it is
increased again. Finally, for the 96 h sample, the R.L.I.
increases with the Eu3+ concentration until reaching
a maximum emission at 0.02 M, and then it decreases for
higher concentrations. For large europium amounts in the
apatitic lattice, a phenomenon of luminescence quenching
might indeed occur due to Eu3+ luminescent centers too close
from each other.
An important parameter in luminescent complexes is the
luminescence lifetime (s). The decrease of the R.L.I. versus
time for 0.001, 0.005 and 0.01 M Eu3+ at 96 h is shown in
Fig. 8. For each case, the decay prole was analyzed as
a single exponential component (R.L.I. ¼ Aet/s + C) obtain-
ing s of 1315, 1147 and 1341 ms, respectively. It is possible to
conclude that the luminescence lifetime for all the tested2394 | RSC Adv , 2018, 8, 2385 2397concentrations are almost the same, of the order of the
millisecond. This order of magnitude is similar to that or
colloidal apatite nanoparticles stabilized with a phospho-
lipid moiety, AEP,47 and points out a long luminescence
lifetime as compared to the auto-uorescence of biologicalThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinematter (of the order of the nanosecond), thus allowing us to
envision applications as biomedical probes. This lumines-
cence is expected to be linked to Eu3+ luminescent centers
(most likely in Ca(II) positions) located in the apatitic lattice
for all the samples studied.3.7 Luminescence properties of Eu-doped cit-cAp
nanoparticles in aqueous suspension
The luminescence properties of the Eu-doped cit-cAp samples
suspended in water are depicted in Fig. 9 which shows the
uncorrected excitation and emission spectra.
The maximum excitation wavelength observed was 232 nm.
The observed emission wavelengths were 592, 616, 648 and
696 nm, which correspond to the Eu3+ ion 5D0/
7F1,
5D0/
7F2,
5D0 /
7F3 and
5D0 /
7F4 transitions, respectively.45 The
emission wavelength corresponding to the hypersensitive
transition without inversion centre (5D0 /
7F2, 616 nm)
produces the highest relative luminescence intensity. There-
fore, the optimum excitation and emission wavelengths of the
Eu-doped material dispersed in water were 232 nm and 616 nm,
respectively.
It is known that the media aﬀect the luminescence intensi-
ties of luminophores.48 In order to obtain a deeper under-
standing, the eﬀects of changes in pH, ionic strength and
temperature were evaluated.
The inuence of pH on the luminescence intensity was
studied over the range 5.0–7.4 (see ESI, Fig. SI5†) for the
materials obtained for x ¼ 0.001, 0.005, 0.010 and 0.020 M
Eu3+at 96 h. For Eu3+doped samples obtained with 0.001 M
Eu3+doping concentration, the R.L.I. remained approximately
constant from pH 5.0 to 6.5. Beyond this pH value a drastic rise
was observed. For the 0.005 M Eu3+ sample the variation is the
opposite, the R.L.I. remained approximately constant from pH
5.0 to 6.5, beyond which a drastic drop was observed. For the
rest of Eu3+ concentrations, the R.L.I. was practically not altered
by the pH. The variation of the R.L.I. with the pH is a complex
phenomenon which could be attributed to the balance between
the tendency of the apatite nanoparticles to dissolve at acidic
pHs and the protection from dissolution oﬀered by citrate layer,
whose amount increases with the concentration of Eu3+ dopingFig. 10 Viability of GTL-16 cells (a) and of m17.ASC cells (b) incubated w
MTT assays. Data represent means  sd of three independent experimen
using one-way ANOVA, with Bonferroni comparison test. For statistical a
0.01, ***p # 0.001).
This journal is © The Royal Society of Chemistry 2018the samples as shown by the evolution of the antisymmetric
stretching frequency of the carboxylate group of citrate at
1590 cm1 in the FTIR spectra of Fig. 4a.
The eﬀect of ionic strength was studied by suspending the
particles in solutions of diﬀerent concentrations of NaCl (0, 25,
50, 75 and 100 mM). The results are shown in Fig. SI6† of ESI.
Overall, the ionic strength did not aﬀect signicantly the
luminescent activity.
Temperature may also theoretically aﬀect luminescence
event by quenching of excited states: increasing T increases
molecular motion and collisions, and hence decreases the
luminescence emission by increasing encounters probabili-
ties.49 Therefore, it is important to know the eﬀect of the T on
this kind of materials because their main application might be
for medical and biomedical imaging (37.4 C) while all the
previous experiments were performed at RT (25 C). Fig. SI7 of
ESI† shows the experimental results obtained when monitoring
the temperature eﬀect. To sum up, increasing from 25 to 37 C
decreases the luminescence emission of all the tested materials
in suspension (0.01, 0.02 and 0.03 M Eu3+, maturation time of
96 h). The change in uorescence intensity is normally 1% per
degree celsius;49 however for these materials the decrease is
found to be somewhat larger, around 1.3, 2.0 and 3.8% per
degree celsius, respectively.3.8 Cytocompatibility of Eu-doped cit-cAp nanoparticles
The cytocompatibility of Eu-doped cit-cAp samples was tested in
a MTT assay on the GTL-16 human carcinoma cells and on the
m17.ASC murine mesenchymal stem cells, aer incubation at
diﬀerent concentrations ranging from 100 to 0.1 mg mL1. No
signicant toxicity was observed on GTL-16 cells at any nano-
particle concentration (Fig. 10a). Indeed in all cases cell viability
was always higher than 83%.
In the case of the mesenchymal stem cells a somehow higher
toxicity was observed in samples prepared with doping
concentrations 0.020 and 0.030 M Eu3+. For these samples the
highest cell viability was around 70–75% of the controls run
with undoped nanoparticles (Fig. 10b). In any case the level
observed is above the cytocompatibility cut-oﬀ (70%) indicated
by ISO 10993-5:2009 (ref. 50) and, moreover, it is largelyith Eu-doped cit-cAp particles for three days. Viability was assessed in
ts performed in quadruplicate and statistical analyses were carried on
nalysis all data were compared to untreated samples (*p# 0.05, **p#
RSC Adv , 2018, 8, 2385 2397 | 2395
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View Article Onlinereported from the literature that cell lines can diﬀer in their
sensitivity to external stimuli.51,52 On the other side, both cell
types were sensitive to the toxic activity of doxorubicin, which
reduced their viability to less than 40%.
This in vitro evaluation thus pointed out the good cyto-
compatibility of the Eu-doped cit-cAp nanoparticles prepared by
the thermal decomplexing method, thus showing promise for
their future biomedical use as luminescent nanoprobes.
4 Conclusions
Luminescent Eu-doped cit-cAp particles were prepared and fully
characterized, for the rst time, using the citrate-based thermal
decomplexing method. This study allowed to determine the
most appropriate experimental conditions, especially in terms
of europium concentration and duration of maturation, so as to
obtain single-phased apatitic particles with nanosized dimen-
sions for which the biomimetic (bone-like) nature was evi-
denced. Their luminescence properties were investigated in
detail, both as powders and suspensions, pointing out their
long luminescence lifetime (of the order of the millisecond),
relevant for biomedical uses. The cytocompatibility of the
particles was then explored on two cell types. The nano-systems
appear to be fully cytocompatible since none of the concentra-
tions assessed in theMTT, ranging from 0.1 to 100 mgmL1, was
found to be signicantly toxic. Consequently, these highly
biocompatible, bio-inspired nanoparticles produced by thermal
decomplexing of citrate complex could represent valuable new
luminescent nanoprobes for applications in biology and
medical imaging, and could also serve in (targeted) cell therapy.
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Figure SI1. XRD patterns of samples precipitated at different maturation times in the presence of a) 
x=0.02 M Eu3+ and b) x = 0.03 M Eu3+. # (OCP, 100, PDF 44-0778), *(apatite phase, PDF 01-
1008),+(EuPO4.H2O phase, PDF 20 1044)
Figure SI2. Excitation (dashed line) and emission (solid line) spectra of Eu3+-cit-cAp prepared with 
different Eu3+ doping concentration at precipitation times of 5 min, 1h, 2h, 4h, 24h, 48h and 96h.
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Figure SI3. Effect of the precipitation time over the R.L.I. of the different Eu3+ doping 
concentrations. λexc/em= 394/614 nm, slit-widthsexc/em= 5/5 nm, td= 0.120 µs, tg= 5 ms and detector 
voltage= 500 v.
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Figure SI4. Effect of the Eu3+ doping concentration over the R.L.I. of the different materials 
precipitated at different times. λexc/em= 394/614 nm, slit-widthsexc/em= 5/5 nm, td=0.120  µs, tg= 5 ms 
and detector voltage= 500 v.
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Figure SI5. Effect of the pH on the luminescence of the different Eu3+ doping concentrations 
dispersed in aqueous solution at 25ºC. λexc/em= 232/616 nm, slit-widthsexc/em= 10/10 nm, td= 0.120µs, 
tg= 5 ms and detector voltage= 600 v.
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Figure SI6. Effect of the ionic strength on the luminescence of the different Eu3+ doping 
concentrations dispersed in aqueous solution at pH=7.0 and 25ºC. λexc/em= 232/616 nm, slit-
widthsexc/em= 10/10  nm, td= 0.120 µs, tg= 5 ms and detector voltage= 600 v.
Figure SI7. Effect of the temperature on the luminescence of the different Eu3+ doping 
concentrations dispersed in aqueous solution at pH=7.0. λexc/em= 232/616 nm, slit-widthsexc/em= 10/10 
nm, td= 0.120µs, tg= 5 ms and detector voltage= 600 v.
